Allogene Therapeutics
ALLO
ALLO
168 hedge funds and large institutions have $3.12B invested in Allogene Therapeutics in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 62 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.87% less ownership
Funds ownership: 63.71% → 62.83% (-0.87%)
29% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 62
Holders
168
Holding in Top 10
5
Calls
$16.5M
Puts
$4.53M
Top Buyers
| 1 | +$20.8M | |
| 2 | +$18.9M | |
| 3 | +$18.9M | |
| 4 |
HM
HealthCor Management
New York
|
+$17.5M |
| 5 |
JPMorgan Chase & Co
New York
|
+$15M |
Top Sellers
| 1 | -$36.7M | |
| 2 | -$18.7M | |
| 3 | -$12.2M | |
| 4 |
CII
Capital International Inc
Los Angeles,
California
|
-$11.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$9.9M |